Cannabinoid CB2Receptors and Fatty Acid Amide Hydrolase Are Selectively Overexpressed in Neuritic Plaque-Associated Glia in Alzheimer's Disease Brains
Top Cited Papers
Open Access
- 3 December 2003
- journal article
- Published by Society for Neuroscience in Journal of Neuroscience
- Vol. 23 (35), 11136-11141
- https://doi.org/10.1523/jneurosci.23-35-11136.2003
Abstract
The endocannabinoid system is still poorly understood. Recently, the basic elements that constitute it, i.e., membrane receptors, endogenous ligands, and mechanisms for termination of the signaling process, have been partially characterized. There is a considerable lack of information, however, concerning the distribution, concentration, and function of those components in the human body, particularly during pathological events. We have studied the status of some of the components of the endocannabinoid system, fatty acid amide hydrolase and cannabinoid CB1and CB2receptors, in postmortem brains from patients with Alzheimer's disease. Using specific polyclonal antibodies, we have performed immunohistochemical analysis in hippocampus and entorhinal cortex sections from brains of Alzheimer's disease patients. Our results show that both fatty acid amide hydrolase and cannabinoid CB2receptors are abundantly and selectively expressed in neuritic plaque-associated astrocytes and microglia, respectively, whereas the expression of CB1receptors remains unchanged. In addition, the hydrolase activity seems to be elevated in the plaques and surrounding areas. Thus, some elements of the endocannabinoid system may be postulated as possible modulators of the inflammatory response associated with this neurodegenerative process and as possible targets for new therapeutic approaches.Keywords
This publication has 36 references indexed in Scilit:
- Astrocytes in Culture Produce Anandamide and Other AcylethanolamidesJournal of Biological Chemistry, 2002
- The fatty acid amide hydrolase (FAAH)Prostaglandins, Leukotrienes & Essential Fatty Acids, 2002
- Endocannabinoids in the immune system and cancerProstaglandins, Leukotrienes & Essential Fatty Acids, 2002
- Endocannabinoids and basal ganglia functionalityProstaglandins, Leukotrienes & Essential Fatty Acids, 2002
- Microglia and the Immune Pathology of Alzheimer DiseaseAmerican Journal of Human Genetics, 1999
- A new perspective on cannabinoid signalling: complimentary localization of fatty acid amide hydrolase and the CB1 receptor in rat brain.Proceedings Of The Royal Society B-Biological Sciences, 1998
- Two novel classes of neuroactive fatty acid amides are substrates for mouse neuroblastoma ‘anandamide amidohydrolase’FEBS Letters, 1995
- Expression of Central and Peripheral Cannabinoid Receptors in Human Immune Tissues and Leukocyte SubpopulationsEuropean Journal of Biochemistry, 1995
- Selective vulnerability in Huntington's disease: Preferential loss of cannabinoid receptors in lateral globus pallidusAnnals of Neurology, 1994
- Age-related loss of cannabinoid receptor binding sites and mRNA in the rat striatumNeuroscience Letters, 1992